Skrzypczynska-Banasik U, Wozniak O, Kowalik I, Fronczak-Jakubczyk A, Borowiec K, Hoffman P
J Clin Med. 2024; 13(17).
PMID: 39274252
PMC: 11396235.
DOI: 10.3390/jcm13175038.
Takase B, Ikeda T, Shimizu W, Abe H, Aiba T, Chinushi M
J Arrhythm. 2024; 40(4):655-752.
PMID: 39139890
PMC: 11317726.
DOI: 10.1002/joa3.13052.
Brito J, Cortez-Dias N, da Silva G, Ferreira A, Ricardo I, Cunha N
J Interv Card Electrophysiol. 2023; 67(5):1133-1143.
PMID: 37966657
DOI: 10.1007/s10840-023-01685-8.
Nomoto M, Suzuki A, Shiga T, Shoda M, Hagiwara N
BMC Cardiovasc Disord. 2022; 22(1):374.
PMID: 35974317
PMC: 9382808.
DOI: 10.1186/s12872-022-02811-6.
Arsenos P, Gatzoulis K, Doundoulakis I, Dilaveris P, Antoniou C, Stergios S
J Arrhythm. 2020; 36(5):890-898.
PMID: 33024466
PMC: 7532265.
DOI: 10.1002/joa3.12416.
Electrophysiological features in acromegaly: re-thinking the arrhythmic risk?.
Parolin M, Dassie F, Vettor R, Steeds R, Maffei P
J Endocrinol Invest. 2020; 44(2):209-221.
PMID: 32632903
DOI: 10.1007/s40618-020-01343-0.
Complexities in cardiovascular rhythmicity: perspectives on circadian normality, ageing and disease.
Monfredi O, Lakatta E
Cardiovasc Res. 2019; 115(11):1576-1595.
PMID: 31150049
PMC: 6933509.
DOI: 10.1093/cvr/cvz112.
Signal-averaged electrocardiography: Past, present, and future.
Gatzoulis K, Arsenos P, Trachanas K, Dilaveris P, Antoniou C, Tsiachris D
J Arrhythm. 2018; 34(3):222-229.
PMID: 29951136
PMC: 6010001.
DOI: 10.1002/joa3.12062.
H558R, a common SCN5A polymorphism, modifies the clinical phenotype of Brugada syndrome by modulating DNA methylation of SCN5A promoters.
Matsumura H, Nakano Y, Ochi H, Onohara Y, Sairaku A, Tokuyama T
J Biomed Sci. 2017; 24(1):91.
PMID: 29202755
PMC: 5713129.
DOI: 10.1186/s12929-017-0397-x.
A Review of Automated Methods for Detection of Myocardial Ischemia and Infarction Using Electrocardiogram and Electronic Health Records.
Ansari S, Farzaneh N, Duda M, Horan K, Andersson H, Goldberger Z
IEEE Rev Biomed Eng. 2017; 10:264-298.
PMID: 29035225
PMC: 9044695.
DOI: 10.1109/RBME.2017.2757953.
Ventricular late potential in cardiac syndrome X compared to coronary artery disease.
Faisal Lutfi M
BMC Cardiovasc Disord. 2017; 17(1):35.
PMID: 28103808
PMC: 5244555.
DOI: 10.1186/s12872-017-0469-6.
Deceleration Capacity of Heart Rate Predicts Arrhythmic and Total Mortality in Heart Failure Patients.
Arsenos P, Manis G, Gatzoulis K, Dilaveris P, Gialernios T, Angelis A
Ann Noninvasive Electrocardiol. 2016; 21(5):508-18.
PMID: 27038287
PMC: 6931782.
DOI: 10.1111/anec.12343.
A novel low-complexity post-processing algorithm for precise QRS localization.
Fonseca P, Aarts R, Foussier J, Long X
Springerplus. 2015; 3:376.
PMID: 26034664
PMC: 4447753.
DOI: 10.1186/2193-1801-3-376.
A cause of falsely high noise level in signal averaged electrocardiogram recordings.
Donoiu I, Mustafa R, Ionescu D
Curr Health Sci J. 2014; 37(4):178-80.
PMID: 24778836
PMC: 3945385.
A hybrid approach to the simultaneous eliminating of power-line interference and associated ringing artifacts in electrocardiograms.
Zhou X, Zhang Y
Biomed Eng Online. 2013; 12:42.
PMID: 23672732
PMC: 3701603.
DOI: 10.1186/1475-925X-12-42.
A method for ventricular late potentials detection using time-frequency representation and wavelet denoising.
Gadaleta M, Giorgio A
ISRN Cardiol. 2012; 2012:258769.
PMID: 22957271
PMC: 3432549.
DOI: 10.5402/2012/258769.
The prevalence and the prognostic value of microvolt T-wave alternans in patients with hypertrophic cardiomyopathy.
Trzos E, Kasprzak J, Krzeminska-Pakula M, Rechcinski T, Wierzbowska-Drabik K, Uznanska B
Ann Noninvasive Electrocardiol. 2011; 16(3):276-86.
PMID: 21762256
PMC: 6932658.
DOI: 10.1111/j.1542-474X.2011.00443.x.
Low noise level unmasks late potentials on signal-averaged electrocardiography.
Frances R
Exp Clin Cardiol. 2010; 15(3):e61-4.
PMID: 20959882
PMC: 2954031.
[Functional late potential analysis in the 24-hour electrocardiogram].
Steinbigler P, Haberl R, Vogel J, Schmucking I, Spiegl A, Steinbeck G
Herzschrittmacherther Elektrophysiol. 2009; 8(4):245-54.
PMID: 19484327
DOI: 10.1007/BF03042615.
Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene.
Merner N, Hodgkinson K, Haywood A, Connors S, French V, Drenckhahn J
Am J Hum Genet. 2008; 82(4):809-21.
PMID: 18313022
PMC: 2427209.
DOI: 10.1016/j.ajhg.2008.01.010.